Visualisation of the heart during bone scintigraphy in a patient with prostatic cancer

被引：0
|
作者：
Giannakis, D
Shina, I
Lathridou, P
Tsabalas, S
Papas, A
Baltogiannis, D
Kafarakis, B
Giannakopoulus, X
Filiadis, I
机构：
来源：
AKTUELLE UROLOGIE | 1998年 / 29卷 / 03期
关键词：
abnormal radiopharmaceutical uptake of the myocardium; prostate cancer; bone scan;
D O I：
10.1055/s-2008-1065279
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report on an 89 year old patient with prostata cancer who underwent bone scintigraphy. During this procedure the myocardium had an abnormal uptake of T(c)99 m MDP. The scintigram showed complete visualisation of the heart without any other concentration in the bones. The patient did not have any major heart abnormality nor had he had any previous treatment with electrocardioversion, chemotherapy or medication. Abnormal radiopharmaceutical uptake in the heart is rare. It can occur in patients having had recent electrocardioversion, treatment with Doxorubicin or myocardial infarction.
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] STAGING OF PROSTATIC CANCER EMPLOYING BONE SCINTIGRAPHY AND RADIOIMMUNOASSAY
    OPLER, SR
    SHEA, LP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 218 - 218
  • [2] DYNAMIC BONE-SCINTIGRAPHY IN PROSTATIC-CANCER
    SUNDKVIST, GMG
    ABRAHAMSSON, PA
    AHLGREN, L
    LILJA, B
    MATTSSON, S
    WADSTROM, LB
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1987, : 8 - 8
  • [3] RADIOISOTOPIC BONE SCINTIGRAPHY WITH GAMMA CAMERA IN INVESTIGATION OF PROSTATIC CANCER
    SHEARER, RJ
    CONSTABLE, AR
    GIRLING, M
    HENDRY, WF
    FERGUSSON, JD
    BMJ-BRITISH MEDICAL JOURNAL, 1974, 2 (5915): : 362 - 365
  • [4] Regression bone metastases in patient with prostatic cancer
    Peyri Rey, E.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (10): : 1050 - 1050
  • [5] PROSTATIC-CANCER - VALUE OF BONE-SCINTIGRAPHY - POINT OF VIEW
    LUMBROSO, J
    GUERMAZI, F
    WIBAULT, P
    HENRYAMAR, M
    TRAVAGLI, JP
    BULLETIN DU CANCER, 1985, 72 (05) : 436 - 441
  • [6] CONTRIBUTION OF TECHNECIUM PYROPHASPHATE BONE SCINTIGRAPHY TO DETERMINATION OF EXTENT OF A PROSTATIC CANCER
    OLIVEUX, A
    LEVIN, G
    METHLIN, G
    BOLLACK, C
    JOURNAL DE MEDECINE DE STRASBOURG, 1977, 8 (02): : 73 - 78
  • [7] THE USEFULNESS OF BONE-MARROW SCINTIGRAPHY IN THE DIRECTION OF BONE METASTASIS FROM PROSTATIC-CANCER
    OTSUKA, N
    FUKUNAGA, M
    SONE, T
    YONEDA, M
    SAITO, N
    TANAKA, H
    TOMOMITSU, T
    YANAGIMOTO, S
    MURANAKA, A
    MORITA, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (08): : 319 - 322
  • [8] Comparison of Serum PSA and whole body bone scintigraphy in patients with prostatic cancer
    Stefanescu, C.
    Rusu, V.
    Rusu, M.
    Costin, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S276 - S276
  • [9] Comparison of Serum PSA and whole body bone scintigraphy in patients with prostatic cancer
    Asabella, A. Niccoli
    Tatulli, F.
    Iuele, F.
    Merenda, N.
    Rubini, D.
    Fanelli, M.
    Lauriero, F.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S276 - S276
  • [10] BONE-MARROW SCINTIGRAPHY IN PROSTATIC CARCINOMAS
    BOURGEOIS, P
    MALARME, M
    VANFRANCK, R
    WAUTERS, G
    FERREMANS, W
    NUCLEAR MEDICINE COMMUNICATIONS, 1991, 12 (01) : 35 - 45
12345